By Vincent Cruz

China’s beauty industry now launches brands at a pace nobody else matches, and the U.S. is the market most of them want next, through Amazon, TikTok Shop, and direct-to-consumer sites. The obstacle is paperwork, not demand. China runs one of the most demanding cosmetics approval systems in the world under the NMPA, and Chinese brands reasonably expect that work to count for something abroad. With FDA, it counts for nothing: the U.S. has its own filings, its own agent requirement, and its own definitions of what a cosmetic even is.

This guide is written for the Chinese brand owner planning to sell in the U.S.: what MoCRA requires of you, where the Chinese and U.S. systems diverge, and the specific mistakes that catch Chinese brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

The core rule: your NMPA registration or filing does not transfer

Everything in this guide follows from one fact: FDA does not recognize Chinese compliance as a substitute for U.S. compliance. Specifically:

Your special cosmetics registration （注册） is a Chinese approval. Hair dyes, perming products, whitening and freckle-removing products, sunscreens, and anti-hair-loss products registered with the NMPA went through real review in China. FDA does not see that record, and several of those categories are not even cosmetics under U.S. law (see the pitfalls below).
Your general cosmetics filing （备案） is a Chinese record. The notification for ordinary cosmetics under the CSAR has no counterpart effect in the U.S. FDA’s product listing is a separate filing in a separate system.
Your domestic responsible person （境内责任人） cannot help you in the U.S. That role exists so a Chinese entity answers to the NMPA for your products inside China. The U.S. agent role points the other direction: a U.S.-based person answering to FDA for your foreign facility. Different role, different country, different person.
Your efficacy claim substantiation stays in China. The evaluation summaries published under CSAR rules satisfy Chinese regulators. U.S. law asks a different question: not “can you prove this claim?” but “does this claim turn your product into a drug?”

Plan your U.S. launch as a fresh compliance project, not an export of your NMPA dossier.

Step 1: Register your facility with FDA

If your products are manufactured or processed in China (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for Chinese brands:

You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
Shenzhen or Guangzhou factory making products for many brands? The facility that manufactures the product is the one that registers, whether it is your own factory or an OEM/ODM partner, and it needs its own U.S. agent. If your factory already produces for U.S. brands, it may already be registered; the FEI check above will tell you. See Private Label Cosmetics: Who Registers Under MoCRA.

A common Chinese-brand mistake: assuming your exporter, trading company, or Amazon service provider’s registrations cover your factory. They do not. The manufacturing facility registers in its own name.

Step 2: Name a U.S. agent

Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and no one in China, including your 境内责任人， your customs broker, or your freight forwarder, can fill the role.

The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. Chinese brands already understand the logic of this role from the domestic responsible person system; the difference is that this one sits in the U.S., answers to FDA, and must be appointed before registration can be completed. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.

Step 3: List your products

Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person (the manufacturer, packer, or distributor whose name appears on the label). Listings include product and ingredient information and must be kept current with annual updates.

Do not confuse this with your Chinese filing. The NMPA filing for general cosmetics and the FDA listing collect overlapping information, but they are independent filings in independent systems, and selling in the U.S. without the FDA listing leaves you non-compliant no matter how complete your Chinese dossier is. For how registration and listing differ, see Facility Registration vs Product Listing Explained.

Step 4: Fix your labels for the U.S. market

Chinese labels need a rebuild for the U.S., not a translation pass. The differences that matter most:

Language. All required label information must be in English, prominent and conspicuous. A translated sticker over a Chinese retail label is the single most common reason marketplace listings get flagged; design a U.S. label instead.

Ingredient declaration. China labels ingredients using Chinese INCI translations in descending order. The U.S. requires English INCI names in descending order of predominance with specific formatting rules. The order mostly transfers; the names and format must be redone.

Net quantity. U.S. consumer commodities must state net quantity in both U.S. customary and metric units, placed in a specific location on the principal display panel. Metric-only declarations need updating.

Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. Many Chinese brands add their U.S. distributor’s information so the label is not misleading about who stands behind the product in the U.S.

Claims review. This is the critical one. Claims that are ordinary in China’s market are drug claims in the U.S.: whitening and freckle-removing （祛斑美白）, anti-hair-loss （防脱发）, anti-acne treatment, “medical-grade” （医用级）, and growth or repair claims all need re-evaluation before the product ships. In the U.S., a claim can reclassify your product as an unapproved drug. See Is Your Product a Cosmetic or a Drug?.

For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.

The pitfalls that catch Chinese brands specifically

The special cosmetics mismatch. China’s “special cosmetics” categories do not map onto U.S. law. Sunscreen is a drug in the U.S. Whitening products make drug claims in the U.S. Anti-hair-loss products claiming regrowth are drugs in the U.S. Your most heavily approved Chinese products are the ones most likely to need a completely different U.S. pathway or a claims rewrite. Sort classification before anything else.
Assuming the NMPA dossier impresses FDA. It is genuinely rigorous, and FDA does not accept it in place of any U.S. filing. Registration, listing, and agent appointment all still apply in full.
Marketplace-first launches. Selling on Amazon or TikTok Shop does not soften the requirements. U.S. marketplaces increasingly ask foreign brands for FDA registration and listing details, and a shipment can be detained at the border before a listing ever gets reviewed. The compliance work is the same whether your first channel is TikTok or a national retailer.
Animal testing assumptions. Since 2021, general cosmetics in China can qualify for exemption from mandatory animal testing with GMP certification and a safety assessment. That exemption is about entering China’s market. The U.S. does not require animal testing for cosmetics, and your Chinese testing status, in either direction, has no bearing on your MoCRA filings.
Relying on the trading company. Your exporter or service provider may offer to “handle U.S. compliance.” They cannot register your factory or serve as your facility’s U.S. agent unless they formally take on that role and meet FDA’s requirements (a China-based company cannot be a U.S. agent at all). Keep control of your own filings.
Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not Chinese revenue, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and record-keeping that FDA can demand to see. See MoCRA Adverse Event Reporting.

A realistic China-to-US launch sequence

Classify every product as cosmetic or drug for the U.S. market (re-do claims and ingredients, not just labels). Special cosmetics get decided first.
Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
Request your facility’s FEI number (7 to 10 business days).
Choose and appoint your U.S. agent.
File facility registration via Cosmetics Direct.
File product listings.
Finalize U.S.-compliant English labels before the first shipment.
Set up adverse event intake and record-keeping from day one.

For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.

FAQ

Do I need a U.S. agent if I only sell on Amazon or TikTok Shop?
Yes. The requirement attaches to the foreign manufacturing facility, not the sales channel. If your products are made outside the U.S. and sold in the U.S., the facility must register and designate a U.S. agent, whatever platform you sell through.

Does my NMPA registration or filing count with FDA?
No. Neither the special cosmetics registration nor the general cosmetics filing has any effect on your U.S. obligations. FDA registration, product listing, and U.S. agent appointment are all separate.

Can my domestic responsible person （境内责任人） also be my U.S. agent?
No. The U.S. agent must be physically present in the United States (residing there or maintaining a U.S. place of business). A China-based person or company does not qualify.

My whitening cream is registered as a special cosmetic in China. Can I sell it in the U.S.?
Not as a cosmetic with whitening claims. In the U.S., products intended to lighten skin pigmentation are regulated as drugs. You would need either the drug pathway or a reformulated product and claims positioned as cosmetics (for example, appearance-based brightening claims that stay within cosmetic limits). Get classification advice before shipping.

Are Chinese cosmetic labels acceptable in the US if I add an English sticker?
Usually not. Beyond language, U.S. rules govern ingredient naming and order format, net quantity in U.S. customary and metric units, name and place of business, warnings, and claims. Design a dedicated U.S. label rather than patching the domestic one.

How long does the whole process take for a Chinese brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.

Next step: Chinese brand planning a U.S. launch? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.